Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

July 2026

Added to Dediabetes Jul 12, 2026RCTs

EDC-HHA01 Improves Glycemic Control in Adults with Prediabetes

This randomized controlled trial investigated the effects of the dietary supplement EDC-HHA01 on metabolic health, finding significant reductions in HbA1c and insulin levels compared to placebo.

Interventions
Synbiotic Formulation EDC-HHA01
Outcomes
Exploratory patient-reported measuresFasting insulin levelsHbA1c+3 more
Added to Dediabetes Jul 12, 2026RCTs

High-dose multivitamins do not reduce cardiovascular events in diabetes

This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.

Interventions
Oral multivitamins and multiminerals (OMVM)
Outcomes
Adverse events incidenceAll-cause mortalityComposite of CV death, non-fatal myocardial infarction, or non-fatal stroke+4 more
Added to Dediabetes Jul 12, 2026RCTs

Lixisenatide shows no significant effect on arterial stiffness in diabetes.

The study evaluated the impact of lixisenatide on aortic pulse wave velocity in patients with CKD and type 2 diabetes, finding no significant changes.

Interventions
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)
Outcomes
AlbuminuriaChange in aortic pulse wave velocity from baseline to week 24HbA1c
Added to Dediabetes Jul 12, 2026RCTs

Luseogliflozin improves glycemic control in older adults with T2D

This study investigated the effects of Luseogliflozin combined with leucine-enriched amino acid supplementation and exercise in older adults with type 2 diabetes. It found a decrease in HbA1c and body weight over 52 weeks.

Interventions
Luseogliflozin
Outcomes
Body fat massBody weightFive-times Sit-to-Stand Test+3 more
Added to Dediabetes Jul 12, 2026RCTs

DSPS Improves Blood Glucose Control in Type 2 Diabetes

The study evaluated the impact of a diabetes-specific protein supplement (DSPS) as a partial breakfast replacement on glycemic control in adults with type 2 diabetes, finding significant reductions in postprandial glucose levels.

Interventions
Diabetes-specific nutritional formula-pro (DSNF-Pro)Isocaloric control breakfast
Outcomes
Glucose iAUC (OGTT)Mean amplitude of glycemic excursions (MAGE)Postprandial blood glucose+2 more
Added to Dediabetes Jul 12, 2026RCTs

Empagliflozin improves glycemic control in HNF1A-MODY

The study evaluated the effects of empagliflozin on glycemic control in adults with HNF1A-MODY, finding significant reductions in glucose levels and improvements in time in range.

Interventions
Empagliflozin
Outcomes
Body weightFasting Plasma Glucose (FPG)Hypoglycemia events+2 more
Added to Dediabetes Jul 12, 2026RCTs

iGlarLixi improves glycemic control and reduces insulin injections in type 2 diabetes

This study evaluated the effectiveness of insulin glargine-lixisenatide fixed-ratio combination (iGlarLixi) in individuals with type 2 diabetes. It found significant improvements in body weight, BMI, and insulin dosage compared to multiple daily injections (MDI).

Interventions
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi)
Outcomes
Body Mass Index (BMI) changeGlycemia risk indexHbA1c+3 more
Added to Dediabetes Jul 12, 2026RCTs

Postpartum lifestyle intervention may reduce type 2 diabetes risk

This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.

Interventions
Integrated Hyperglycaemia Incentivized Postnatal Surveillance (IHIPS)
Outcomes
Cost-effectiveness assessmentDietary intake changesGestational diabetes mellitus incidence+2 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.